JNJ vs JPM: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and JPMorgan Chase & Co. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-15.
Johnson & Johnson · Healthcare
$253.85
-21.7% upside to fair value
Grade D
High Quality
VS
JPMorgan Chase & Co. · Financial Services
$334.53
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
JPM has more upside to fair value
(+45.0%).
JPM trades at a lower forward P/E
(14.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
JPM |
| Current Price |
$253.85 |
$334.53 |
| Fair Value Estimate |
$198.76 |
$485.07 |
| Upside to Fair Value |
-21.7%
|
+45.0%
|
| Market Cap |
$611.1B |
$896.4B |
| Forward P/E |
29.3x
|
14.3x
|
| EV / EBITDA |
19.2x
|
12.4x
|
| Price / Sales |
6.3x
|
5.4x
|
| Price / FCF |
34.3x
|
6.4x
|
| Revenue Growth YoY |
+9.9%
|
-168.4%
|
| Gross Margin |
69.1%
|
78.6%
|
| Operating Margin |
26.9%
|
33.7%
|
| Return on Equity |
26.3%
|
17.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.91%
|
15.72%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
Johnson & Johnson is a leading healthcare conglomerate operating primarily in the drug manufacturing sector, known for its durable competitive moat supported by strong brand recognition and intangible assets. The company exhibits high business quality with a 26.3% return on equity and robust gross and net margins of 69.1% and 21.8%, respectively. However, earnings have faced significant pressure,…
JPMorgan Chase & Co. operates as a leading diversified bank within the financial services sector, demonstrating a high-quality business model characterized by a strong return on equity of 17.8% and robust profitability margins including a net margin of 38.9%. Despite a significant revenue decline of 168.4% year-over-year in the most recent quarter, earnings grew by 41.2%, reflecting operational e…
Accumulation Zones
| Metric |
JNJ |
JPM |
| Zone Low |
$149.07 |
$363.80 |
| Zone High |
$168.95 |
$412.31 |
| In Buy Zone? |
No
|
Yes
|